NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,674 | +5.5% | 45,889 | +4.6% | 1.16% | +11.7% |
| Q2 2023 | $4,429 | +14.6% | 43,887 | +4.5% | 1.04% | +7.0% |
| Q1 2023 | $3,864 | +4.8% | 41,997 | +3.4% | 0.97% | -1.0% |
| Q4 2022 | $3,686 | -99.9% | 40,627 | -12.0% | 0.98% | -31.9% |
| Q3 2022 | $3,508,000 | -5.5% | 46,151 | +5.1% | 1.44% | +0.4% |
| Q2 2022 | $3,712,000 | -2.5% | 43,913 | +1.2% | 1.43% | +13.6% |
| Q1 2022 | $3,809,000 | +3.8% | 43,413 | +3.5% | 1.26% | +13.0% |
| Q4 2021 | $3,671,000 | +8.8% | 41,964 | +1.7% | 1.12% | -0.2% |
| Q3 2021 | $3,375,000 | -10.0% | 41,268 | +0.4% | 1.12% | -8.4% |
| Q2 2021 | $3,750,000 | +9.7% | 41,095 | +2.8% | 1.22% | -16.4% |
| Q1 2021 | $3,417,000 | +0.8% | 39,970 | +11.3% | 1.46% | -6.4% |
| Q4 2020 | $3,390,000 | +6.8% | 35,900 | -1.6% | 1.56% | -4.8% |
| Q3 2020 | $3,173,000 | +0.5% | 36,485 | +0.9% | 1.64% | -6.9% |
| Q2 2020 | $3,157,000 | +9.8% | 36,150 | +3.7% | 1.76% | -8.4% |
| Q1 2020 | $2,874,000 | -8.4% | 34,860 | +5.2% | 1.92% | +18.7% |
| Q4 2019 | $3,139,000 | +36.5% | 33,151 | +25.3% | 1.62% | +25.2% |
| Q3 2019 | $2,299,000 | +3.4% | 26,461 | +8.6% | 1.29% | +0.4% |
| Q2 2019 | $2,224,000 | -3.2% | 24,361 | +2.0% | 1.29% | -6.7% |
| Q1 2019 | $2,297,000 | +20.3% | 23,891 | +7.4% | 1.38% | +3.2% |
| Q4 2018 | $1,909,000 | +5.9% | 22,241 | +6.3% | 1.34% | +23.5% |
| Q3 2018 | $1,803,000 | +13.4% | 20,929 | -0.6% | 1.08% | +6.6% |
| Q2 2018 | $1,590,000 | -2.5% | 21,054 | +4.3% | 1.02% | -5.9% |
| Q1 2018 | $1,631,000 | +10.7% | 20,179 | +14.9% | 1.08% | +16.0% |
| Q4 2017 | $1,474,000 | +71.2% | 17,558 | +75.1% | 0.93% | +53.6% |
| Q3 2017 | $861,000 | +22.5% | 10,028 | +19.0% | 0.61% | +4.7% |
| Q2 2017 | $703,000 | -23.4% | 8,428 | -22.0% | 0.58% | -30.5% |
| Q1 2014 | $918,000 | +4.8% | 10,800 | -0.9% | 0.83% | +3.7% |
| Q4 2013 | $876,000 | -55.4% | 10,900 | -57.4% | 0.80% | -56.9% |
| Q3 2013 | $1,964,000 | +8.9% | 25,600 | +0.4% | 1.86% | +2.1% |
| Q2 2013 | $1,803,000 | +2.9% | 25,500 | +3.7% | 1.82% | -1.4% |
| Q1 2013 | $1,753,000 | – | 24,600 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |